80120-03-2

Usage

Uses

Used in Pharmaceutical Research:
4-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE is used as a research tool for the development of new medications, particularly in the field of medicinal chemistry.
Used in Pain Management:
4-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE is used as an analgesic for the management of pain.
Used in Neurological Disorders Treatment:
4-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE is used as a potential treatment for neurological disorders such as Parkinson's disease and anxiety, as it modulates neurotransmitter systems in the brain.
Used in Preclinical Studies:
4-(3-METHYLPHENYL) PIPERIDINE HYDROCHLORIDE is used in preclinical studies to evaluate its efficacy and safety in treating neurological disorders and managing pain.

Upstream product

• 591-17-3 meta-bromotoluene 
• 1370256-33-9 1-benzyl-4-(3-methylphenyl)-1,2,3,6-tetrahydropyridinium chloride 
• 634466-57-2 1-benzyl-4-(3-methyl-phenyl)-piperidin-4-ol 
• 3612-20-2 1-phenylmethyl-4-piperidone 

Downstream Products

• 1345688-67-6 1-(3-acetyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-4-[4-(3-methylphenyl)piperidin-1-yl]butan-1-one 

Relevant academic research and scientific papers

Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6- tetrahydropyridines as 5-HT2C agonists

A series of substituted 4-arylpiperidines and a smaller family of 4-aryl-1,2,3,6-tetrahydropyridines were synthesized and their biological activity at the 5-HT2C receptor studied to determine whether either series showed noteworthy agonist activity. Structure-activity relationships were developed from the performed receptor binding assays and functional studies, and the results of the analysis are presented herein.

AZABENZIMIDAZOLYL COMPOUNDS

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I), as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

BENZIMIDAZOLYL COMPOUNDS AS POTENTIATORS OF MGLUR2 SUBTYPE OF GLUTAMATE RECEPTOR

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Benzoylpiperidylalkylindoles

New benzoylpiperidylalkylindoles and related compounds possessing tranquilizing, anti-hypertensive and analgesic properties and a process for the preparation thereof are described.